fBw2e5/6k&Dd:/7(lc\s56l<6E'0$tumU? W@mZ_$3ZwE]^ Continue Infed until hemoglobin is within the normal range and iron stores are replete. For males: LBW = 50 kg + 2.3 kg for each inch of patients height over 5 feet All Rights Reserved. Administer test dose prior to first therapeutic dose. . 1986;17(1):1-10. doi: 10.1007/BF00299858. Disease-Associated Maternal and/or Embryo/Fetal Risk (See Special Populations under Pharmacokinetics.). Ling J, Gupta VD. . 0000005669 00000 n 4. 0000014709 00000 n Protect from light. The need for chemical compatibility studies of subcutaneous medication combinations used in palliative care. 0000009983 00000 n For information on systemic interactions resulting from concomitant use, see Interactions. This site needs JavaScript to work properly. The half-life of free iron in the plasma circulation is approximately 5 hours. INFeD preparation: Administer by deep IM injection using a 2- or 3-inch, 19- or 20-gauge needle into the upper outer quadrant of the buttock only. PDF INFeD See full prescribing information for complete boxed warning tran [6]. . . 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility The animals used in these tests were not iron deficient. During all Infed administrations, observe patients for signs or symptoms of anaphylactic-type reactions. Before Improper storage conditions after reconstitution will lead to the administration of a subtherapeutic medication and will eventually lead to treatment failure and antibiotic resistance. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. $ Watson Pharma, Inc. I. Infed may cause falsely elevated values of serum bilirubin and falsely decreased values of serum calcium. If patient is standing, administer IM injection in buttock of the leg opposite the patients weight-bearing leg; if supine, place patient in a lateral position with the injection site uppermost. Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported following the parenteral administration of iron dextran products, including Infed. Anemia Associated with Chronic Renal Failure, Hypersensitivity Reactions [see Warnings and Precautions (5.1)], Delayed Reactions [see Warnings and Precautions (5.2)], Increased Risk of Toxicity in Patients with Underlying Conditions [see Warnings and Precautions (5.3)], Iron Overload [see Warnings and Precautions (5.4)], Fetal bradycardia [see Use in Specific Populations (8.1)]. ], Observed Hb = the patients current hemoglobin in g/dL. NoPEF(djUMPU}ocl`<0yxk0R7?+9Ks,y Advise patients to inform their healthcare provider if any liver impairment is identified as this may cause iron toxicity. Administer test dose prior to administration of initial and subsequent therapeutic doses of the drug and observe patient closely. endobj PDF 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE - Allergan . PDF Evaluation of the stability of vancomycin solutions at concentrations Infed is not recommended for use in infants under 4 months of age [see Dosage and Administration (2.2)]. 4. INFeD is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response. The molecular weights of INFeD and DexFerrum are 165,000 and 267,000 daltons, respectively. Infed is given undiluted at a slow gradual rate not to exceed 50 mg (1 mL) per minute.
Dorset Sheep Disadvantages,
Poorest Footballer In The World,
Newsies Splasher Lines,
Ideologically Oriented Programming Definition Ap Gov,
Articles I